Erste Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,400
Closed -$207K 603
2022
Q3
$207K Hold
10,400
﹤0.01% 494
2022
Q2
$75.2K Hold
10,400
﹤0.01% 542
2022
Q1
$98.1K Hold
10,400
﹤0.01% 517
2021
Q4
$145K Hold
10,400
﹤0.01% 502
2021
Q3
$231K Hold
10,400
﹤0.01% 469
2021
Q2
$261K Hold
10,400
0.01% 460
2021
Q1
$256K Hold
10,400
0.01% 437
2020
Q4
$379K Buy
+10,400
New +$453K 0.01% 413

Erste Asset Management's FMTX Position: Q4 2022 in Review

Erste Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 10,400 shares — an estimated $207K sold.

Erste Asset Management first reported a position in FMTX in Q4 2020 and held it in 8 quarters. The position peaked at $379K in Q4 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Erste Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Erste Asset Management sold 10,400 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $207K.
  • Erste Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Erste Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $379K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Erste Asset Management's 13F filing for Q4 2022, filed 26 Nov 2024.